Anhui Kedun Biotechnology

Anhui Kedun Biotechnology is a China-based biotechnology company specializing in the research, development, and production of high-end pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company focuses heavily on metabolic health, particularly providing key components for GLP-1 receptor agonists used in treating diabetes and obesity. Their product portfolio includes specialized amino acids, protected amino acids, and peptide fragments essential for large-scale peptide synthesis. Anhui Kedun operates advanced manufacturing facilities that adhere to international quality standards to support global pharmaceutical supply chains. By bridging the gap between chemical synthesis and biological application, the company serves as a critical supplier for the modern biopharmaceutical industry.